« Previous
Next »
Radiotherapy & Oncology
Volume 95, Issue 1
, Pages 79-86
, April 2010
Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy
References
- . Antiprotons target cancer. Phys World. 2003;12:
- Investigation on the use of anti-protons in clinical radiotherapy. Radiother Oncol. 2002;64:S52;(Abstract)
- Biological effectiveness of antiproton annihilation. Nuclear Instrum Methods Phys Res B. 2004;221:210–214
- . Antiproton portable traps and medical applications. Hyperfine Interact. 1997;107:155–164
- Potential for a radiotherapeutic gain from an anti-proton beam. Radiother Oncol. 2002;64:S93
- Antiproton radiotherapy. Radiother Oncol. 2008;86:14–19
- . The antiproton depth-dose curve in water. Phys Med Biol. 2008;53:793–805
- . Antiprotons for radiotherapy?. Radiother Oncol. 2006;81:231–232
- . Possible biomedical applications of antiproton beams: focused radiation transfer. Radiat Res. 1984;97:246–252
- Biological effectiveness of antiproton annihilation. Nuclear Instrum Methods Phys Res B. 2004;214:181–185
- The biological effectiveness of antiproton irradiation. Radiother Oncol. 2006;81:233–242
- GEANT4 – a simulation toolkit. Nuclear Instrum Methods Phys Res. 2003;A 506:250–303
- . Monte Carlo calculations for absolute dosimetry to determine output factors for proton therapy treatments. Phys Med Biol. 2006;51:2801–2812
- . Test of Geant3 and Geant4 nuclear models for 160
MeV protons stopping in CH2. Med Phys. 2003;30:1926–1931 - . Accurate Monte Carlo for nozzle design, commissioning, and quality assurance in proton therapy. Med Phys. 2004;31:2107–2118
- . Physics settings for using the Geant4 toolkit in proton therapy. IEEE Trans Nucl Sci. 2008;55:1018–1025
- Ferrari A, Sala PR, Fasso A, Ranft J. FLUKA: a multi-particle transport code. CERN Yellow Report CERN 2005-10; INFN/TC 05/11, SLAC-R-773. Geneva: CERN; 2005.
- . A measurement of the local energy deposition by antiprotons coming to rest in tissue-like material. Phys Med Biol. 1985;30:1297–1303
- . Low energy antiproton–nucleus interactions. Phys Rev C. 1982;26:2138–2151
- Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53:407–421
- . A heavy particle comparative study. Part III: OER and RBE. Br J Radiol. 1978;51:712–719
- . A heavy particle comparative study. Part II: cell survival versus depth. Br J Radiol. 1978;51:704–711
- . Direct comparison of biologically optimized spread-out Bragg peaks for protons and carbon ions. Int J Radiat Oncol Biol Phys. 2008;70:262–266
- pp annihilation cross section at very low energy. Phys Lett B. 1996;369:77–85
- . A phenomenological analysis of antiproton interactions at low energies. Phys Lett B. 2000;483:353–359
- Antiproton–nucleon annihilation process (antiproton collaboration experiment). Phys Rev. 1957;105:1037–1058
- . Antiproton–nucleon annihilation process. II. Phys Rev. 1959;113:1615–1634
- Antiproton interactions in hydrogen and carbon below 200
MeV. Phys Rev. 1960;118:1371–1391 - . Low-energy anti-proton physics. Ann Rev Nucl Particle Sci. 1991;41:219–267
- . Assessment of the prompt radiation hazards of trapped antiprotons. Health Phys. 2003;84:747–755
- . Branching ratios in proton antiproton annihilation from Skyrmion dynamics. Phys Lett B. 1995;357:446–450
- Annihilation at rest of antiprotons and protons into neutral particles. Nucl Phys A. 2003;720:357–367
- Review of particle properties. Phys Lett B. 1990;239:1–516
- Branching ratios for p_bar p annihilation at rest into two-body final states. Nucl Phys A. 2001;679:563–576
- Observation of radiative p_bar p annihilation into a Φ meson. Phys Lett B. 1995;346:363–370
- Proton–antiproton annihilations at rest into π0η, π0γ, π0π, π0π0, and π0η′. Nucl Phys. 1983;B228:424–438
- pbar p partial cross sections at low energy. Nucl Phys B (Proc Suppl). 1997;56A:58–65
PII: S0167-8140(09)00141-8
doi: 10.1016/j.radonc.2009.03.020
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Radiotherapy & Oncology
Volume 95, Issue 1
, Pages 79-86
, April 2010
